Feed

28/03/2023
CMS wins with GE Health­care in Fed­er­al So­cial Court
Ham­burg – On Feb­ru­ary 22, 2023, the Fed­er­al So­cial Court ruled that a be­ne­fit as­sess­ment and a price reg­u­la­tion for a medi­cin­al product with a new act­ive in­gredi­ent is un­law­ful for lack of a leg­al basis...
23/03/2023
European Pat­ent Of­fice (EPO) dig­ging its heals in over the need for de­scrip­tion...
As a com­ple­ment to the 10th edi­tion of the EPO "Case Law of the Boards of Ap­peal" (CLB), the EPO has pub­lished an An­nu­al Re­view con­tain­ing sum­mar­ies of de­cisions from 2022. The re­view provides a them­at­ic...
22/03/2023
CMS European M&A Study 2023 | Press re­lease
Re­cord num­ber of deals last year des­pite chal­len­ging eco­nom­ic back­drop
22/03/2023
European Pat­ent Of­fice (EPO) level of dis­clos­ure re­quired for an­ti­bod­ies...
As a com­ple­ment to the 10th edi­tion of the EPO "Case Law of the Boards of Ap­peal" (CLB), the EPO has pub­lished an An­nu­al Re­view con­tain­ing sum­mar­ies of de­cisions from 2022. The re­view provides a them­at­ic...
22/03/2023
CMS European M&A Study 2023
The CMS Cor­por­ate/M&A Group is pleased to launch the 15th edi­tion of the European M&A Study
21/03/2023
Is a pa­tient in a clin­ic­al tri­al con­sidered to be a mem­ber of the pub­lic...
In T 0670/20, the ques­tion was wheth­er the in­tern­al struc­ture of medi­cin­al tab­lets had been made avail­able to the pub­lic by pa­tients tak­ing part in clin­ic­al tri­als in­volving ad­min­is­tra­tion of the tab­lets...
21/03/2023
CMS ad­vises Chart In­dus­tries on ac­quis­i­tion of Howden for USD 4.4 bn
Stut­tgart – CMS, led by M&A part­ner Dr To­bi­as Grau, ad­vised Chart In­dus­tries, Inc. (NYSE: GTLS) (“Chart”) on the com­pleted ac­quis­i­tion of Howden, a lead­ing glob­al pro­vider of mis­sion crit­ic­al air...
21/03/2023
Di­git­al health apps and telemedi­cine in Ger­many
Di­git­al Health Apps/Soft­ware 1. How is the soft­ware with­in di­git­al health apps clas­si­fied in your jur­is­dic­tion, and what reg­u­la­tion(s) ap­ply? Soft­ware as a med­ic­al deviceSoft­ware with­in di­git­al health...
Comparable
21/03/2023
Whis­tleblower pro­tec­tion and re­port­ing chan­nels in Ger­many
1. Is there a law on whis­tleblow­ing in your coun­try? There is no law on whis­tleblow­ing yet. However, in April 2022 the Fed­er­al Min­istry of Justice and Con­sumer Pro­tec­tion is­sued a draft bill for a...
Comparable
20/03/2023
Out with the old, in with the new? Con­sid­er­a­tions for pat­entees in opt­ing...
So far in this series of blog posts, we began with an art­icle that high­lighted some of the key changes between the cur­rent European sys­tem of pat­ent pro­sec­u­tion and en­force­ment and the new Unit­ary Pat­ent...
29/03/2023
We­bin­ar: Get­ting to grips with changes to con­sumer reg­u­la­tion
At a time when com­pet­i­tion for cus­tom­er spend is high, don’t fall foul of changes to con­sumer pro­tec­tion law.The risks of non-com­pli­ance are sub­stan­tial - repu­ta­tion­al dam­age, civil and crim­in­al pen­al­ties and loss of busi­ness.Join our we­bin­ar on Wed­nes­day 29 March to un­der­stand the re­quire­ments of the Di­git­al Ser­vices Act, dark pat­terns and the new price re­duc­tion ob­lig­a­tions un­der the Price In­dic­a­tion Dir­ect­ive.We will also dis­cuss spe­cif­ic con­sumer law de­vel­op­ments in the UK, Ger­many and Spain.The we­bin­ar will be mod­er­ated by Katie Nagy de Nagybaczon, Part­ner & Co-Head of Con­sumer Products Sec­tor Group and will in­clude the fol­low­ing ex­perts:Melanie Shef­ford - Of Coun­sel, Tech­no­logy, Me­dia and Com­mu­nic­a­tions Alf­onso Codes - Part­ner, Pub­lic Law & Reg­u­lated Sec­tor­sJuan Moreno - Coun­sel, Pub­lic Law & Reg­u­lated Sec­torsStefan Lüft - Part­ner, In­tel­lec­tu­al Prop­erty
17/03/2023
In­ter­Di­git­al v Len­ovo – High Court sets glob­al FRAND li­cence terms
The UK High Court has handed down its de­cision in the FRAND tri­al of the In­ter­Di­git­al v Len­ovo lit­ig­a­tion. It con­cerned In­ter­Di­git­al, an Amer­ic­an com­pany hold­ing pat­ents rel­ev­ant to 3G, 4G and 5G tech­no­logy...